companydata.dkcompanydata.dk

Eurofins Genomics Denmark A/S: Financial statements 2012

CVR: 10048818

Source: annual report 2012, Danish Business Authority

01/01/2012 – 31/12/2012

Eurofins Genomics Denmark A/S (CVR 10048818) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 22,504,216 and a net result of DKK 3,393,255. Equity in the 2012 report amounted to DKK 14,869,704. The solvency ratio was 32.3%.

Gross Profit
DKK 22,504,216
Profit/Loss
DKK 3,393,255
Equity
DKK 14,869,704
Total Assets
DKK 46,107,124

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Eurofins Genomics Denmark A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2012

Auditor steps down at Eurofins Genomics Denmark A/SDec 31, 2012

As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of Eurofins Genomics Denmark A/S.

About Eurofins Genomics Denmark A/S

Eurofins Genomics Denmark A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Eurofins Genomics Europe AgriGenomics Products & Services A/S and Eurofins Genomics Europe Genotyping A/S. The management consists of Jacob Sickmann Ransborg. The board consists of Svend Aage Linde (chair), Jacob Sickmann Ransborg and Ulrich August Werner Kühle. The company is owned by Eurofins Genomics LUX Holding SARL. The company has 68 employees (2026). In 2025, the company reported a gross profit of DKK 43,634,455 and a net result of DKK -8,643,885 compared with DKK -12,812,295 the year before. Equity in the 2025 report amounted to DKK 14,211,619.

Source: annual report 2025, Danish Business Authority